Request for Proposals

Click here to receive future RFPs

MRA is the largest non-profit funder of melanoma research. MRA’s investment in the field has been critical in catalyzing transformative, strategic, and collaborative investments in scientific discovery and translation.

Each year, MRA selects new research awards to address critical unmet needs in melanoma detection, prognostication, and treatment. All grant awards selected by MRA’s Grant Review Committee through a diligent peer review process and confirmed by the MRA Board of Directors. To date, MRA has invested over $110 million in life-saving melanoma research, in addition to $150 million in outside, leveraged funds.

Learn more about specific MRA-funded awards or about MRA grant mechanisms

MRA Request for Proposals:

Click here to receive future RFPs


Questions: 

Tasheema Prince, MRA Scientific Program Manager  

tprince@curemelanoma.org

About Melanoma

Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma. 

Login

×